Clinical trial Recruiting at 1 site Interventional Ages 55 and up

COMPASS: Home transition program to reduce disability after stroke

Official title: Compass 3: A Novel Transition Program to Reduce Disability After a Stroke

Run by Washington University School of Medicine · NCT07069660 · Data updated 2026-11-12

This program will test whether a home-focused environmental modifications intervention helps people aged 55 and older returning home from inpatient stroke rehabilitation do everyday activities better than a standard stroke education program.

Quick facts

Study typeInterventional
Ages55 Years and up
SexAll
Enrollment520 (estimated)
SponsorWashington University School of Medicine
Academic / other
Locations2 sites (Columbia, Missouri and 1 other locations)
StatusRecruiting
StartedSeptember 29, 2025
Main results expectedMarch 31, 2030
Study endsMarch 31, 2030
Registry record updatedFebruary 13, 2026
Trial IDNCT07069660 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 55 or older with a recent ischemic or hemorrhagic stroke who were independent before the stroke and plan to be discharged to home from inpatient rehabilitation and can give informed consent.

Probably not a fit

Patients with severe cognitive or communication impairments that prevent informed consent or completion of study activities, those living in congregate care, or those with life expectancy under six months are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will run a randomized, controlled multi-center trial comparing a compensatory environmental modifications intervention (COMPASS) to a standard stroke education program for people discharged home after an ischemic or hemorrhagic stroke. Participants are randomized at discharge from inpatient rehabilitation and the study collects outcomes on daily activity performance, participation, cost-effectiveness, and implementation processes. A concurrent implementation evaluation and process-data review will examine how the intervention is delivered, barriers to uptake, and potential scalability. The trial is conducted at sites in Missouri and targets adults who were independent before their stroke and able to consent.

Why it matters

Potential benefit: If successful, the COMPASS approach could increase independence in daily activities and reduce long-term disability for people returning home after stroke.

How similar studies have gone: Smaller single-site and pilot studies of home modifications and compensatory occupational therapy approaches have shown promising improvements in function, but this multi-center randomized trial tests broader effectiveness and implementation potential.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged ≥55 years at the time of screening
* Acute stroke diagnosis (IS or ICH) verified by the stroke team or medical record
* Independent in activities of daily living (ADLs) prior to stroke (premorbid Modified Rankin Scale score ≤2)
* Plan to discharge to home from an IR
* Capable of giving informed consent which includes compliance with the requirements and duration of participation as listed in the Informed Consent Form (ICF).

Exclusion Criteria:

* Life expectancy \<6 months
* Cognitive impairment that the participant's stroke team or a research team member believes impairs their ability to provide informed consent or make reasoned choice including the interpretation of the self-rated scales
* Any communication problem that would prevent study completion
* Residence in a congregate living facility
* Not eligible for a therapeutic pass
* Residence outside of the designated catchment area (specific catchment distance to be determined by each site)
* Site investigator's judgment that the participant would not be able to complete research procedures or interventions
* Participation in another research study that in the site investigator's judgment could interfere or conflict with this research study's assessments or interventions

Where it's running

  • Washington University in St. Louis
    St Louis, Missouri, United States
    Recruiting
  • University of Missouri
    Columbia, Missouri, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Susan Stark, PhD — Washington University School of Medicine
  • Study coordinator: Susan Stark, PhD
  • Email: sstark@wustl.edu
  • Phone: (314)935-2551

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.